APA (7th ed.) Citation

Burkett, P., Chalkias, S., Umans, K., Castrillo‐Viguera, C., Purcell, D. D., Barakos, J., . . . Haeberlein, S. B. (2021). Considerations for the real‐world management of ARIA from the aducanumab phase 3 studies EMERGE and ENGAGE. Alzheimer's & dementia: the journal of the Alzheimer's Association, 17, 1. https://doi.org/10.1002/alz.057498

Chicago Style (17th ed.) Citation

Burkett, Patrick, Spyros Chalkias, Kimberly Umans, Carmen Castrillo‐Viguera, Derk D. Purcell, Jerome Barakos, Sami Fam, Karen Smirnakis, and Samantha Budd Haeberlein. "Considerations for the Real‐world Management of ARIA from the Aducanumab Phase 3 Studies EMERGE and ENGAGE." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 17 (2021): 1. https://doi.org/10.1002/alz.057498.

MLA (9th ed.) Citation

Burkett, Patrick, et al. "Considerations for the Real‐world Management of ARIA from the Aducanumab Phase 3 Studies EMERGE and ENGAGE." Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 17, 2021, p. 1, https://doi.org/10.1002/alz.057498.